RxDoctor Payments DataLook up a doctor →

Christopher Romero

Internal Medicine · Houston, TXNPI 1053671263

Payments from drug & device makers

$8,421,264in general payments, 2019–2025

Across 865 payments — averaging $9735.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$2.8M
  • Pfizer$2.1M
  • Eli Lilly$924K
  • AstraZeneca$796K
  • Valneva Austria GmbH$627K
  • Boehringer Ingelheim$592K
  • plus $529K from 12 others
$32,947in research payments, 2019–2025

Across 9 payments — averaging $3660.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$28K
  • Valneva Austria GmbH$5K

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,421,264 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Other internal medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →